IPO registrations (S-1, F-1) · Underwriters

Dawson James

Deals
52 priced offerings as an underwriter, 33 as lead manager or representative; 29 initial public offerings
Proceeds of those deals
$1,426,785,272 ($693,220,806 as lead)
Years
2006–2026
Named in
106 prospectuses and registration statements in all, including offerings not yet priced or withdrawn

Deals by year

YearDealsAs leadProceeds of deals
202611$10,000,000
202511$3,348,002
202443$24,712,091
202322$110,289,189
202210$150,000,000
202183$601,059,890
202033$38,688,415
201942$21,556,252
201830$22,340,185
201742$28,613,386
201611$11,040,000
201543$104,300,003
201453$42,637,500
201310$8,982,858
201222$15,000,025
201011$9,335,963
200911$20,032,169
200811$5,775,000
200743$178,304,342
200611$20,770,000

Deals 52

PricedCompanyRolePriceRangeSharesProceedsListingKindSyndicateProspectus
2026-01-13Green Circle Decarbonize Technology Ltd K3Lead$4.002,500,000$10,000,000NYSE American GCDTIPO4424B4 ↗
2025-02-19Petros Pharmaceuticals, Inc. NYLead$0.2413,950,012$3,348,002Nasdaq PTPIOffering1424B4 ↗
2024-12-27Park Ha Biological Technology Co., Ltd. F4Lead$4.001,200,000$4,800,000IPO2424B4 ↗
2024-11-26Wing Yip Food Holdings Group Ltd F4Lead$4.002,050,000$8,200,000Nasdaq WYHGIPO2424B4 ↗
2024-11-14Glucotrack, Inc. NJSyndicate$1.394,756,900$6,612,091Nasdaq GCTKOffering3424B4 ↗
2024-08-29Safe Pro Group Inc. FLLead$5.001,020,000$5,100,000Nasdaq SPAIIPO3424B4 ↗
2023-09-29Ascent Solar Technologies, Inc. COLead$2.883,572,635$10,289,189Nasdaq ASTIOffering1424B4 ↗
2023-06-15ESH Acquisition Corp. NYLead$10.0010,000,000$100,000,000Nasdaq ESHIPO2424B4 ↗
2022-05-11Global Blockchain Acquisition Corp. FLSyndicate$10.0015,000,000$150,000,000Nasdaq GBBKIPO2424B4 ↗
2021-12-22Profusa, Inc. NYSyndicate$10.0016,500,000$165,000,000Nasdaq NVACIPO2424B4 ↗
2021-11-12Bluejay Diagnostics, Inc. MALead$10.002,160,000$21,600,000Nasdaq BJDXIPO4424B4 ↗
2021-10-15Bone Biologics Corp MASyndicate$5.251,510,455$7,929,889OTC BBLGOffering5424B4 ↗
2021-04-12Global SPAC Partners Co, DELead$10.0016,000,000$160,000,000Nasdaq GLSPTIPO2424B4 ↗
2021-02-26Isleworth Healthcare Acquisition Corp. FLSyndicate$10.0018,000,000$180,000,000Nasdaq ISLEIPO3424B4 ↗
2021-02-12GT Biopharma, Inc. CALead$5.504,300,000$23,650,000Nasdaq GTBPOffering2424B4 ↗
2021-02-11E-Power Inc.Syndicate$4.006,720,000$26,880,000Nasdaq SDHIPO4424B4 ↗
2021-01-25COMSovereign Holding Corp. AZSyndicate$4.153,855,422$16,000,001Nasdaq COMSOffering3424B4 ↗
2020-12-28INTELLIGENT BIO SOLUTIONS INC. NYLead$17.00-$21,600,013Nasdaq GBSIPO5424B4 ↗
2020-07-01Aditxt, Inc. VALead$9.001,226,668$11,040,012Nasdaq ADTXIPO5424B4 ↗
2020-02-14Scienture Holdings, Inc. NYLead$7.50806,452$6,048,390Nasdaq MEDSOffering4424B4 ↗
2019-08-05BioCardia, Inc. CASyndicate$6.001,666,667$10,000,002OTCQB BCDAOffering3424B4 ↗
2019-05-29TuHURA Biosciences, Inc./NV FLLead$1.00--Nasdaq DMPIOffering2424B4 ↗
2019-02-13IMAC Holdings, Inc. TNLead$5.12850,000$4,356,250Nasdaq IMACIPO4424B4 ↗
2019-01-09MMTEC, INC.Syndicate$4.001,800,000$7,200,000Nasdaq MTCIPO4424B4 ↗
2018-12-10Tonix Pharmaceuticals Holding Corp. NJSyndicate$3.50861,710$3,015,985Nasdaq TNXPOffering3424B4 ↗
2018-07-30Azora Therapeutics, Inc. (DE) CASyndicate$5.001,464,000$7,320,000Nasdaq ADILIPO4424B4 ↗
2018-02-15Biofrontera AG 2MSyndicate$9.881,215,000$12,004,200Nasdaq BFRAIPO4424B4 ↗
2017-12-22Grace Therapeutics, Inc. NJSyndicate$1.019,900,990$9,990,098Nasdaq ACSTOffering2424B4 ↗
2017-11-03ENvue Medical, Inc. TXLead$4.901,224,488$5,999,991OTCQB NAOVOffering1424B4 ↗
2017-08-04Citius Pharmaceuticals, Inc. NJSyndicate$4.121,648,484$6,799,996Nasdaq CTXRIPO2424B4 ↗
2017-02-16NextTrip, Inc. FLLead$4.13$4.00–$6.001,410,000$5,823,300Nasdaq SGLBOffering1424B4 ↗
2016-05-06F-star Therapeutics, Inc. X0Lead$12.00920,000$11,040,000Nasdaq SBPHIPO1424B4 ↗
2015-12-18NAKED BRAND GROUP INC. NYLead$4.001,875,000$7,500,000OTCQB NAKDIPO1424B4 ↗
2015-08-27AXE COMPUTE INC. FLLead$9.001,666,667$15,000,003OTCQB SKLN.QBOffering1424B4 ↗
2015-07-27Healthier Choices Management Corp. FLSyndicate$11.00-$41,800,000Nasdaq VPCOOffering3424B4 ↗
2015-04-08Chaince Digital Holdings Inc. NYLead$10.004,000,000$40,000,000Nasdaq WOWOIPO6424B4 ↗
2014-11-18BNB PLUS CORP. NYSyndicate$3.24--Nasdaq APDNOffering5424B4 ↗
2014-11-13SOLENO THERAPEUTICS INC CASyndicate$6.501,650,000$10,725,000Nasdaq CAPNIPO3424B4 ↗
2014-10-10Great Basin Scientific, Inc. UTLead$7.001,150,000$8,050,000Nasdaq GBSNIPO3424B4 ↗
2014-08-13usell.com, Inc. NYLead$3.001,550,000$4,650,000 USELOffering1424B4 ↗
2014-03-21Pulmatrix, Inc. MALead$7.252,650,000$19,212,500Nasdaq RTGNIPO2424B4 ↗
2013-12-16RiceBran Technologies TXSyndicate$5.241,714,286$8,982,858Nasdaq RIBTOffering3424B4 ↗
2012-11-09ATOSSA THERAPEUTICS, INC. WALead$5.00800,000$4,000,000Nasdaq ATOSIPO1424B4 ↗
2012-06-21Sonnet BioTherapeutics Holdings, Inc. NJLead$4.502,444,450$11,000,025OTC CCLR.OBIPO2424B4 ↗
2010-09-30SEELOS THERAPEUTICS, INC. NYLead$5.401,728,882$9,335,963Nasdaq APRIOffering1424B4 ↗
2009-10-02BIONOVO INC CALead$6.203,230,995$20,032,169Nasdaq BNVIOffering1424B4 ↗
2008-02-21U.S. Stem Cell, Inc. FLLead$5.251,100,000$5,775,000Nasdaq BHRTIPO2424B4 ↗
2007-10-30NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ CALead$2.7521,818,181$59,999,998Nasdaq NTIIOffering1424B4 ↗
2007-10-26Stablecoin Development Corp FLLead$4.005,000,000$20,000,000NYSE American NBYIPO4424B4 ↗
2007-10-24FUQI INTERNATIONAL, INC. F4Syndicate$9.007,033,816$63,304,344Nasdaq FUQIIPO11424B4 ↗
2007-06-14HERON THERAPEUTICS, INC. /DE/ CALead$1.6521,212,121$35,000,000Nasdaq APPAOffering1424B4 ↗
2006-10-31VIRAGEN INC FLLead$0.3167,000,000$20,770,000NYSE American VRA.WSOffering1424B4 ↗

“Offering” is a priced registered offering that the cover page does not describe as an initial public offering: a follow-on, a resale, or a small company’s best-efforts deal.

Registrations in progress or never priced 10

FiledCompanyRoleRangeSharesListingStatusDocument
2026-04-14First Choice Healthcare Solutions, Inc.Lead3,800,000Withdrawn 2026-09-15S-1/A ↗
2025-09-30RenX Enterprises Corp.Syndicate320,000Nasdaq SGDWithdrawn 2023-11-16S-1/A ↗
2024-05-31Scripps Safe, Inc.Lead1,410,000Cboe SSAIPendingS-1/A ↗
2022-04-19Gaming Technologies, Inc.Syndicate901,961OTCQB GMGTEffective 2020-12-15S-1/A ↗
2022-04-14Oxeia Biopharmaceuticals, Inc.Lead$6.00–$8.00-Nasdaq OXEAWithdrawn 2022-06-08S-1 ↗
2021-05-20NUGENEREX IMMUNO-ONCOLOGY, INC.Lead5,555,556Nasdaq NGIOPendingS-1/A ↗
2020-09-14GENEREX BIOTECHNOLOGY CORPLead1,000,000Nasdaq GNBTPWithdrawn 2005-03-11S-1/A ↗
2014-12-15Workhorse Group Inc.Syndicate-OTC AMPDWithdrawn 2015-01-16S-1 ↗
2008-01-29Lumax Acquisition Corp.Lead3,593,750PendingS-1/A ↗
2005-12-12Confluence Acquisition Partners I, Inc.Lead8,000,000OTC andPendingS-1/A ↗

Works alongside

FirmDeals togetherOf which that firm led
ViewTrade92
James Securities, Inc62
Newbridge Securities61
of Contents60
The Benchmark Company64
I-Bankers Securities53
Maxim Group55
Securities, Inc30
Axiom Capital Management20
Chardan20
D. Boral Capital21
WallachBeth Capital21

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Offering terms are read from the cover pages of the registrant's final prospectus (424B4, 424B1) and its latest registration statement before pricing: the price range, the final price, shares offered, gross proceeds (the cover's total, else price times shares), exchange and ticker, and the underwriters named on the cover and in the underwriting table (loader/s1_terms.py). Underwriter names are normalised, so Goldman, Sachs & Co. of 1999 and Goldman Sachs & Co. LLC of 2024 are one firm.